Kevin Ali - Feb 28, 2022 Form 4 Insider Report for Organon & Co. (OGN)

Role
Chief Executive Officer, Director
Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Kevin Ali
Stock symbol
OGN
Transactions as of
Feb 28, 2022
Transactions value $
-$243,040
Form type
4
Date filed
3/2/2022, 05:46 PM
Previous filing
Aug 19, 2021
Next filing
Apr 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Options Exercise +14.5K +330.05% 18.9K Feb 28, 2022 Direct F1
transaction OGN Common Stock Tax liability -$243K -6.47K -34.17% $37.57 12.5K Feb 28, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Restricted Stock Units Options Exercise $0 -14.5K -100% $0.00 0 Feb 28, 2022 Common Stock 14.5K Direct F1, F2, F3

Explanation of Responses:

Id Content
F1 Each restricted stock unit converts into one share of Organon & Co. common stock.
F2 As originally reported on the Form 4, dated June 4, 2021, these Restricted Stock Units vested on December 31, 2021. These Restricted Stock Units were subsequently distributed to the Reporting Person on February 28, 2022.
F3 The amount of the Restricted Stock Units has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations.